Introduction
Pancreatic cancer is the fourth leading cause of cancer-related mortality in the United States and both incidence and mortality are higher in African Americans than in other racial/ethnic groups (1, 2).
Pancreatic cancer is usually detected at a late stage and 5-year survival is 5.4% (3) . Cigarette smoking (4) and diabetes (5) are the two factors most consistently associated with pancreatic cancer. Evidence from the past decade indicates that overweight and obesity are also associated with pancreatic cancer (6, 7) .
Chronic pancreatitis is a risk factor for pancreatic cancer but explains only a small proportion of the disease (8) .
The prevalence of obesity is disproportionately high in African Americans (9) , but only three studies have published on the role of obesity in relation to pancreatic cancer in African Americans, with conflicting findings (10) (11) (12) . The largest, the Cancer Prevention Study II, found that obesity was associated with an increased risk of pancreatic cancer death among African American men, but not among African American women (10); a second study observed an association in women, but not men (11) ; and the third, of men only, found no association (12) .
In the present study, we combined data from seven U.S. prospective cohort studies with large number of African American participants in order to have greater statistical power to assess the relation of obesity to pancreatic cancer mortality.
Materials and Methods
The following cohort studies contributed data to the analysis: Adventist Health Study 2 (AHS2) (13) , Black Women's Health Study (BWHS) (14), Cancer Prevention Study II (CPS-II) (10) , Multiethnic Cohort Study (MEC) (15) , National Institutes of Health-AARP Diet and Health Study (NIH-AARP) (16) , Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) (17) , and Southern Community Cohort Study (SCCS) (18) . Enrollment periods and numbers of African American participants for each study are presented in Table 1 . Each study was approved by the relevant Institutional Review Board.
Deaths were identified in each study through linkage with the National Death Index. Pancreatic cancer mortality was defined using International Classification of Diseases (ICD) codes for an underlying cause of death of C25 (ICD-10) or 157 (ICD-9). Data on height, weight, and potential risk factors for pancreatic cancer were obtained by self-report at time of enrollment in each cohort. Body mass index (BMI) was calculated as weight in kilograms divided by squared height in meters and was categorized as <18. excluding non-melanoma skin cancer; heart disease/heart attack; or stroke) at baseline. SAS version 9.3
(SAS Institute Inc., Cary, NC) was used for the analyses.
To assess heterogeneity between cohorts, a meta-analysis was performed using study-specific results for 5 kg/m 2 increments of BMI in relation to pancreatic cancer mortality and a Cochran's Q statistic was calculated. The meta-analysis used a random effects model (STATA 12 software, StataCorp, College Station, TX). The corresponding forest plot was created using Forest Plot Viewer (22) .
Results
Selected baseline characteristics of the study population are shown in Table 1 . Mean age at baseline ranged from 39 to 61 years and was 52 years overall. Seventy-one percent of participants were women. The majority of participants were either overweight (36% with BMI 25-29.9) or obese (33% with BMI ≥30). As expected, obese participants were less likely than lean participants to be current smokers or to consume alcohol, and had less education and a higher prevalence of diabetes (data not shown).
In follow-up of 239,597 participants for a mean of 11.6 years, 897 pancreatic cancer deaths occurred. BMI was not associated with pancreatic cancer mortality among participants with <5 years of follow-up (Table 2 ). Among those with ≥5 years of follow-up, multivariable HRs were 1.25 (95% CI, 0.99-1.57) and 1.31 (95% CI, 0.97-1.77) for BMI 30-34 and BMI ≥35, respectively, in relation to BMI 18.5-24.9 (P trend = 0.03). The HR for the collapsed category of BMI ≥30 was 1.27 (95% CI, 1.03-1.56).
Results were generally similar among men and women. All further analyses were conducted in the combined group of men and women and were restricted to follow-up time occurring at least five years after study enrollment. Table 3 presents results stratified by age, cigarette smoking, and years of education. BMI was more strongly associated with pancreatic cancer mortality among never smokers than among ever smokers (P interaction = 0.02). Results were similar for current smokers and former smokers (data not shown). The association of BMI with pancreatic cancer mortality was more evident in the more educated participants, but there was not a statistically significant interaction (P interaction = 0.72).
Controlling for a history of diabetes did not materially change the estimates; the multivariable HR for BMI ≥35 was 1.30 (95% CI, 0.96-1.76) with inclusion of a term for history of diabetes and 1.31 (95% CI, 0.97-1.77) without the term. Excluding participants with diabetes or with other major diseases (cancer, myocardial infarction, and/or stroke) also did not materially affect the results; HRs for BMI ≥35 
Discussion
The present findings suggest that obesity is associated with increased pancreatic cancer mortality in African Americans, in both women and men. The association was most apparent in persons who had never smoked, who would have had a lower baseline risk of pancreatic cancer. Study-specific HRs varied, with two slightly below 1.0 and one at 1.0. The variation in results may simply be due to chance variation, given the small number of cases in those three studies. These studies also had the highest proportions of men (43% in AARP, 44% in PLCO, and 42% in SCCS,) and our overall results showed a weaker association in men than women. We are aware of only three prior studies reporting on the relation of BMI to pancreatic cancer incidence or mortality in African Americans, with mixed results. In an earlier report from the prospective CPS-II including 360 pancreatic cancer deaths, the HR for BMI ≥30 was 1.66 (95% CI, 1.05-2.63) for men and 0.82 (95% CI, 0.56-1.18) for women (10 
pancreatic cancer deaths from CPS-II are included in the present study. In a case-control study involving 159 African American cases, a high BMI was associated with increased risk of pancreatic cancer among women, but not among men (11) . Finally, obesity was not associated with risk of pancreatic cancer (83 deaths) among African Americans in a cohort study of U.S. male veterans (12) .
BMI has been positively associated with either incidence of or mortality from pancreatic cancer in most (6, (10) (11) (12) (23) (24) (25) (26) (27) , but not all (24-26) studies, which have primarily included White participants (10, 16, 23, (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) . Estimates from the largest of these studies were similar to the results of the present study. In 900,053 participants from the predominantly White CPS-II, higher BMI was associated with increased risk of pancreatic cancer mortality (P trend < 0.01), with similar results for men and women and a stronger relationship among never smokers (28) . In the Million Women Study, a follow-up study of 1.3 million British women, BMI was positively associated with both pancreatic cancer incidence and mortality; the relative risk for BMI ≥32.5 was 1.42 (standard error = 0.12) for incidence and 1.36 (standard error = 0.10) for mortality (23) . In a meta-analysis that included 9,504 cases of pancreatic cancer from 23 prospective studies, each 5 kg/m 2 increase in BMI was associated with a 10% increase in risk of pancreatic cancer (38) .
In our study and in many of the previous positive studies in predominantly White populations (15, 16, 28, 35, 36) , an association was observed only among never smokers or was stronger in never smokers than in smokers. Smokers have an increased risk of pancreatic cancer and it may be more difficult to detect an association of BMI with pancreatic cancer mortality risk in a group at high risk.
The prevalence of obesity is somewhat higher among African Americans than among Whites (9).
However, the magnitude of the association between BMI and pancreatic cancer mortality observed in the present study suggests that BMI is likely to be only a modest contributor to the higher rate of pancreatic cancer death among African Americans compared to Whites.
A central mechanism hypothesized to link obesity to pancreatic cancer mortality is inflammation, as described in a recent review (39) . Obesity can create chronic inflammation and proinflammatory cytokines have been implicated in cancer progression (6, 39 levels of tumor necrosis factor-alpha (TNF-α) and of interleukin-6 (IL-6) and these cytokines have a positive association with cancer-related death (39) . Additionally, obesity tends to reduce serum concentrations of adiponectin, which has anti-inflammatory and insulin-sensitizing properties and can regulate apoptosis and cell proliferation (39).
Our study has several strengths. The data come from prospective cohort studies, which permitted collection of data on exposures prior to diagnosis of pancreatic cancer. Pooling of data across large cohort studies enabled us to accrue a substantial sample size of pancreatic cancer deaths. Further, we were able to harmonize data on the confounding variables and to examine several potential effect modifiers. In particular, we were able to conduct analyses that excluded the first 5 years of follow-up, when results may be influenced by weight loss due to pancreatic cancer.
Limitations include our inability to consider measures of body size other than body mass index, such as waist circumference or waist-hip ratio. We did not have extensive data on comorbidities which could affect the relation of BMI to mortality. Nevertheless, a sensitivity analysis did not show a difference in effect estimates when participants who reported cancer, heart disease, or stroke were excluded. We were unable to differentiate between Type 1 and Type 2 diabetes; however, because Type 2 diabetes comprises 90-95% of diabetes cases (40) and all participants included in our analyses were at least 30 years old, this limitation is unlikely to have materially affected our results. Additionally, we did not observe a change in the HRs when sensitivity analyses controlled for history of diabetes or were restricted to participants who did not report a diabetes diagnosis.
We conclude that obesity is associated with an increased risk of pancreatic cancer death among African American men and women. In addition, consistent with results from other populations, body mass index in African Americans may be more strongly associated with pancreatic cancer mortality among those who have never smoked. [ Figure 1 ] a Multivariable models adjusted for age, sex, cigarette smoking, education, marital status, alcohol consumption, and physical activity. b AHS2 was not included in the meta-analysis due to a small sample size (2 deaths and 11,576 personyears). With AHS2 (HR = 0.68; 95% CI, 0.07-6.38) included, the overall HR is unchanged and P heterogeneity = 0.67. 
